These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 19139809)

  • 1. Mortality of COPD patients infected with multi-resistant Pseudomonas aeruginosa: a case and control study.
    Montero M; Domínguez M; Orozco-Levi M; Salvadó M; Knobel H
    Infection; 2009 Feb; 37(1):16-9. PubMed ID: 19139809
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pseudomonas aeruginosa and mortality after hospital admission for chronic obstructive pulmonary disease.
    Almagro P; Salvadó M; Garcia-Vidal C; Rodríguez-Carballeira M; Cuchi E; Torres J; Heredia JL
    Respiration; 2012; 84(1):36-43. PubMed ID: 21996555
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk factors and clinical outcomes of nosocomial multi-drug resistant Pseudomonas aeruginosa infections.
    Cao B; Wang H; Sun H; Zhu Y; Chen M
    J Hosp Infect; 2004 Jun; 57(2):112-8. PubMed ID: 15183240
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effectiveness and safety of colistin for the treatment of multidrug-resistant Pseudomonas aeruginosa infections.
    Montero M; Horcajada JP; Sorlí L; Alvarez-Lerma F; Grau S; Riu M; Sala M; Knobel H
    Infection; 2009 Oct; 37(5):461-5. PubMed ID: 19499183
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antibiotics against Pseudomonas aeruginosa for COPD exacerbation in ICU: a 10-year retrospective study.
    Planquette B; Péron J; Dubuisson E; Roujansky A; Laurent V; Le Monnier A; Legriel S; Ferre A; Bruneel F; Chiles PG; Bedos JP
    Int J Chron Obstruct Pulmon Dis; 2015; 10():379-88. PubMed ID: 25733827
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Pseudomonas aeruginosa in chronic obstructive pulmonary disease].
    Wavre-Oberhänsli A; Nicod LP
    Rev Med Suisse; 2010 Nov; 6(272):2240-3. PubMed ID: 21207736
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Nosocomial infections caused by multiresistant Pseudomonas aeruginosa (carbapenems included): predictive and prognostic factors. A prospective study (2016-2017))].
    Hernández A; Yagüe G; García Vázquez E; Simón M; Moreno Parrado L; Canteras M; Gómez J
    Rev Esp Quimioter; 2018 Apr; 31(2):123-130. PubMed ID: 29564870
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sputum bacteriology in hospitalized patients with acute exacerbation of chronic obstructive pulmonary disease in Taiwan with an emphasis on Klebsiella pneumoniae and Pseudomonas aeruginosa.
    Lin SH; Kuo PH; Hsueh PR; Yang PC; Kuo SH
    Respirology; 2007 Jan; 12(1):81-7. PubMed ID: 17207030
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sporadic isolations of a multi-drug resistant Pseudomonas aeruginosa clone during a 14-month epidemic in a general hospital in Hiroshima.
    Kouda S; Fujiue Y; Watanabe Y; Ohara M; Kayama S; Kato F; Hisatsune J; Tsuruda K; Matsubara A; Doi M; Kuwabara M; Sugai M
    Infection; 2011 Jun; 39(3):247-53. PubMed ID: 21512791
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effectiveness of antibiotic combination therapy as evaluated by the Break-point Checkerboard Plate method for multidrug-resistant Pseudomonas aeruginosa in clinical use.
    Nakamura I; Yamaguchi T; Tsukimori A; Sato A; Fukushima S; Mizuno Y; Matsumoto T
    J Infect Chemother; 2014 Apr; 20(4):266-9. PubMed ID: 24486172
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Implications of COPD in patients admitted to the intensive care unit by community-acquired pneumonia.
    Rello J; Rodriguez A; Torres A; Roig J; Sole-Violan J; Garnacho-Montero J; de la Torre MV; Sirvent JM; Bodi M
    Eur Respir J; 2006 Jun; 27(6):1210-6. PubMed ID: 16510452
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Epidemiology and drug susceptibility of Pseudomonas aeruginosa strains isolated in the Chugoku region of Japan. Infection Forum in the Chugoku Region].
    Kuwabara M; Kusano N; Shimizu E; Shimizu W; Kobayashi K; Koda S; Doi M; Sugai M; Kumon H
    Jpn J Antibiot; 2011 Apr; 64(2):97-108. PubMed ID: 21721248
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pseudomonas aeruginosa isolates in severe chronic obstructive pulmonary disease: characterization and risk factors.
    Gallego M; Pomares X; Espasa M; Castañer E; Solé M; Suárez D; Monsó E; Montón C
    BMC Pulm Med; 2014 Jun; 14():103. PubMed ID: 24964956
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Study of the cases with multidrug-resistant Pseudomonas aeruginosa by sputum culture].
    Okimoto N; Nanba F; Kibayashi T; Kishimoto M; Yamato K; Kurihara T; Honda Y; Osaki K; Asaoka N
    Nihon Kokyuki Gakkai Zasshi; 2007 Oct; 45(10):755-8. PubMed ID: 18018622
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Successful Use of Ceftolozane-Tazobactam to Treat a Pulmonary Exacerbation of Cystic Fibrosis Caused by Multidrug-Resistant Pseudomonas aeruginosa.
    Vickery SB; McClain D; Wargo KA
    Pharmacotherapy; 2016 Oct; 36(10):e154-e159. PubMed ID: 27522066
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Antimicrobial treatment of patients with severe acute exacerbation of COPD].
    Klapdor B; Ewig S
    Med Klin Intensivmed Notfmed; 2012 Apr; 107(3):179-84. PubMed ID: 22434337
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bacteriological differences between COPD exacerbation and community-acquired pneumonia.
    Li XJ; Li Q; Si LY; Yuan QY
    Respir Care; 2011 Nov; 56(11):1818-24. PubMed ID: 21605476
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correlation between outbreaks of multidrug-resistant Pseudomonas aeruginosa infection and use of bronchoscopes suggested by epidemiological analysis.
    Machida H; Seki M; Yoshioka N; Yabuno K; Miyawaki K; Yoshida H; Yamamoto N; Hamaguchi S; Tomono K
    Biol Pharm Bull; 2014; 37(1):26-30. PubMed ID: 24389477
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Risk factors and clinical outcomes of nosocomial infections caused by multidrug resistant Pseudomonas aeruginosa].
    Cao B; Wang H; Zhu YJ; Chen MJ
    Zhonghua Jie He He Hu Xi Za Zhi; 2004 Jan; 27(1):31-5. PubMed ID: 14989823
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Microbiologic determinants of exacerbation in chronic obstructive pulmonary disease.
    Rosell A; Monsó E; Soler N; Torres F; Angrill J; Riise G; Zalacaín R; Morera J; Torres A
    Arch Intern Med; 2005 Apr; 165(8):891-7. PubMed ID: 15851640
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.